MXPA04005838A - Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su prepacion y las composiciones farmaceuticas que los contienen. - Google Patents

Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su prepacion y las composiciones farmaceuticas que los contienen.

Info

Publication number
MXPA04005838A
MXPA04005838A MXPA04005838A MXPA04005838A MXPA04005838A MX PA04005838 A MXPA04005838 A MX PA04005838A MX PA04005838 A MXPA04005838 A MX PA04005838A MX PA04005838 A MXPA04005838 A MX PA04005838A MX PA04005838 A MXPA04005838 A MX PA04005838A
Authority
MX
Mexico
Prior art keywords
group
sequels
alkyl group
disease
benzothia
Prior art date
Application number
MXPA04005838A
Other languages
English (en)
Inventor
Lestage Pierre
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MXPA04005838A publication Critical patent/MXPA04005838A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • C07D285/181,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/201,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/221,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/241,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se describen los compuestos de la formula (I):(ver formula I),En donde:R1 representa un grupo hidroxilo o un grupo RCO-O-,R2 representa un atomo de hidrogeno, un atomo de halogeno o un grupo hidroxilo, o un grupo R??CO-O,R, R?? los cuales pueden ser identicos o diferentes, representan un grupo alquilo lineal o ramificado de 1 a 6 atomos de carbono opcionalmente sustituidos con un grupo arilo, un grupo alquelino lineal o ramificado de 2 a 6 atomos de carbono, opcionalmente sustituido con un grupo arilo, un grupo perhaloalquilo lineal o ramificado de 1 a 6 atomos de carbono, un grupo cicloalquilo de 3 a 7 atomos de carbono, un grupo adamantilo, un grupo arilo o un grupo heteroarilo,R3 representa un atomo de hidrogeno, un grupo alquilo lineal o ramificado de 1 a 6 atomos de carbono, o un grupo cicloaquilo de 3 a 7 atomos de carbono,A representa un grupo CR4R5 o un grupo NR4,R4 representa un atomo de hidrogeno o un grupo alquilo lineal o ramificado de 1 a 6 atomos de carbono,Sus isomeros y sus sales de adicion con un acido o base farmaceuticamente aceptableLos medicamentos.
MXPA04005838A 2001-12-21 2002-12-20 Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su prepacion y las composiciones farmaceuticas que los contienen. MXPA04005838A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116622A FR2833950B1 (fr) 2001-12-21 2001-12-21 Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2002/004484 WO2003053947A1 (fr) 2001-12-21 2002-12-20 Derives de benzothia(dia)zine et leur utilisation comme modulateurs ampa

Publications (1)

Publication Number Publication Date
MXPA04005838A true MXPA04005838A (es) 2004-09-10

Family

ID=8870810

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005838A MXPA04005838A (es) 2001-12-21 2002-12-20 Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su prepacion y las composiciones farmaceuticas que los contienen.

Country Status (26)

Country Link
US (1) US7250411B2 (es)
EP (1) EP1456189B1 (es)
JP (1) JP2005517668A (es)
KR (1) KR100606606B1 (es)
CN (1) CN1606550A (es)
AR (1) AR038029A1 (es)
AT (1) ATE366245T1 (es)
AU (1) AU2002365017B2 (es)
BR (1) BR0215145A (es)
CA (1) CA2471057A1 (es)
DE (1) DE60221041T2 (es)
DK (1) DK1456189T3 (es)
EA (1) EA007271B1 (es)
ES (1) ES2289182T3 (es)
FR (1) FR2833950B1 (es)
GE (1) GEP20063758B (es)
HU (1) HUP0402584A2 (es)
MA (1) MA27089A1 (es)
MX (1) MXPA04005838A (es)
NO (1) NO20042684L (es)
NZ (1) NZ533330A (es)
PL (1) PL369767A1 (es)
PT (1) PT1456189E (es)
UA (1) UA78743C2 (es)
WO (1) WO2003053947A1 (es)
ZA (1) ZA200404296B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856065B1 (fr) * 2003-06-13 2005-08-19 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2856064B1 (fr) * 2003-06-13 2005-08-19 Servier Lab Nouveaux derives de benzothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2865474B1 (fr) * 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2877342B1 (fr) * 2004-11-03 2007-01-26 Servier Lab Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2877338B1 (fr) * 2004-11-03 2007-01-26 Servier Lab Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0724625D0 (en) * 2007-12-18 2008-01-30 Glaxo Group Ltd Novel compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0636124A1 (fr) * 1992-04-15 1995-02-01 Aventis Pharma S.A. Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
IL137720A0 (en) * 1998-02-18 2001-10-31 Neurosearch As Compounds and their use as positive ampa receptor modulators
FR2801587B1 (fr) * 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CN1606550A (zh) 2005-04-13
ZA200404296B (en) 2005-06-01
JP2005517668A (ja) 2005-06-16
NO20042684L (no) 2004-06-25
EA007271B1 (ru) 2006-08-25
US20050014744A1 (en) 2005-01-20
EP1456189B1 (fr) 2007-07-04
NZ533330A (en) 2006-05-26
AU2002365017A1 (en) 2003-07-09
DE60221041D1 (de) 2007-08-16
PT1456189E (pt) 2007-09-20
PL369767A1 (en) 2005-05-02
WO2003053947A1 (fr) 2003-07-03
UA78743C2 (en) 2007-04-25
DE60221041T2 (de) 2008-04-10
FR2833950A1 (fr) 2003-06-27
ATE366245T1 (de) 2007-07-15
AU2002365017B2 (en) 2007-12-13
EP1456189A1 (fr) 2004-09-15
GEP20063758B (en) 2006-02-27
EA200400756A1 (ru) 2004-10-28
US7250411B2 (en) 2007-07-31
BR0215145A (pt) 2004-10-19
CA2471057A1 (fr) 2003-07-03
HUP0402584A2 (hu) 2005-04-28
ES2289182T3 (es) 2008-02-01
AR038029A1 (es) 2004-12-22
KR100606606B1 (ko) 2006-08-01
MA27089A1 (fr) 2004-12-20
KR20040065276A (ko) 2004-07-21
DK1456189T3 (da) 2007-11-05
FR2833950B1 (fr) 2005-12-16

Similar Documents

Publication Publication Date Title
ATE266013T1 (de) 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4)
NO994960D0 (no) Tricykliske forbindelser
WO2005092895A3 (en) Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
NO20092832L (no) Fremgangsmate for karbonylering av en forbindelse
BR0311771A (pt) Derivados de nonano e azabiciclo-octano com atividade inibitória da ddp-iv
ATE287393T1 (de) Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung
CY1109890T1 (el) ΠΑΡΑΓΩΓΑ 8-ΥΠΟΚΑΤΕΣΤΗΜΕΝΗΣ-6,7,8,9- ΤΕΤΡΑΫΔΡΟΠΥΡΙΜΙΔΟ[1,2-α] ΠΥΡΙΜΙΔΙΝ-4-ΟΝΗΣ
ATE201195T1 (de) Tricyclische verbindungen
MXPA05009574A (es) Derivados de 8'-piridinil- dihidrospiro -[cicloalquil]- pirimido[1, 2a] pirimidin-6- ona y y 8'-pirimidinil- dihidrospiro -[cicloalquil]- pirimido [1, 2a]pirimidin-6 -ona substituidos y su uso contra enfermedades neurodegenerativas.
CA2379026A1 (en) Substituted thiene-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones
DE69613710D1 (de) Benzoxazepinverbindungen, ihre herstellung und verwendung als lipidsenker
MXPA04005838A (es) Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su prepacion y las composiciones farmaceuticas que los contienen.
ATE157966T1 (de) 22-oxacholecalziferol-derivate und ihre herstellung
HUP9800649A2 (hu) Benzil-oxi-csoporttal helyettesített, kondenzált N-heterociklusos vegyületek, eljárás előállításukra és alkalmazásuk bradikinin receptorantagonistaként
BR9103951A (pt) Composicao anti-incrustante aquatica
AU2002214325A1 (en) Process for producing carbapenem-type antibacterial
MXPA04005837A (es) Nuevos derivados de benzotiazina y benzotiadiazina, metodo para su preparacion y composiciones farmaceuticas que los contienen.
DK0554794T3 (da) Aminobenzoesyrederivater
BR0214971A (pt) Processo para a produção de um imunossupressor
GB0428137D0 (en) Novel herbicides
WO2000027378A3 (en) Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
DK1433480T3 (da) Lægemiddel indeholdende pyrimidin-derivat
MXPA04000139A (es) Uso de compuestos biciclo para tratar enfermedad de alzheimer.
TW200712054A (en) Method for producing 2,3-dihydropyridazine compound
TH72865A (th) อนุพันธ์เบนโซอิล-ปิเปอราซีน

Legal Events

Date Code Title Description
FG Grant or registration